Cargando…

Safe Subunit Green Vaccines Confer Robust Immunity and Protection against Mucosal Brucella Infection in Mice

Brucellosis is a zoonotic disease that causes significant negative impacts on the animal industry and affects over half a million people worldwide every year. The limited safety and efficacy of current animal brucellosis vaccines, combined with the lack of a licensed human brucellosis vaccine, have...

Descripción completa

Detalles Bibliográficos
Autores principales: Abushahba, Mostafa F., Dadelahi, Alexis S., Lemoine, Emily L., Skyberg, Jerod A., Vyas, Swati, Dhoble, Sagar, Ghodake, Vinod, Patravale, Vandana B., Adamovicz, Jeffrey J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051820/
https://www.ncbi.nlm.nih.gov/pubmed/36992130
http://dx.doi.org/10.3390/vaccines11030546
_version_ 1785014982345228288
author Abushahba, Mostafa F.
Dadelahi, Alexis S.
Lemoine, Emily L.
Skyberg, Jerod A.
Vyas, Swati
Dhoble, Sagar
Ghodake, Vinod
Patravale, Vandana B.
Adamovicz, Jeffrey J.
author_facet Abushahba, Mostafa F.
Dadelahi, Alexis S.
Lemoine, Emily L.
Skyberg, Jerod A.
Vyas, Swati
Dhoble, Sagar
Ghodake, Vinod
Patravale, Vandana B.
Adamovicz, Jeffrey J.
author_sort Abushahba, Mostafa F.
collection PubMed
description Brucellosis is a zoonotic disease that causes significant negative impacts on the animal industry and affects over half a million people worldwide every year. The limited safety and efficacy of current animal brucellosis vaccines, combined with the lack of a licensed human brucellosis vaccine, have led researchers to search for new vaccine strategies to combat the disease. To this end, the present research aimed to evaluate the safety and efficacy of a green vaccine candidate that combines Brucella abortus S19 smooth lipopolysaccharide (sLPS) with Quillaja saponin (QS) or QS-Xyloglucan mix (QS-X) against mucosal brucellosis in BALB/C mice. The results of the study indicate that administering two doses of either sLPS-QS or sLPS-QS-X was safe for the animals, triggered a robust immune response, and enhanced protection following intranasal challenge with S19. Specifically, the vaccine combinations led to the secretion of IgA and IgG1 in the BALF of the immunized mice. We also found a mixed IgG1/IgG2a systemic response indicating evidence of both Th1 and Th2 activation, with a predominance of the IgG1 over the IgG2a. These candidates resulted in significant reductions in the bioburden of lung, liver, and spleen tissue compared to the PBS control group. The sLPS-QS vaccination had conferred the greatest protection, with a 130-fold reduction in Brucella burdens in lung and a 55.74-fold reduction in the spleen compared to PBS controls. Vaccination with sLPS-QS-X resulted in the highest reduction in splenic Brucella loads, with a 364.6-fold decrease in bacterial titer compared to non-vaccinated animals. The study suggests that the tested vaccine candidates are safe and effective in increasing the animals’ ability to respond to brucellosis via mucosal challenge. It also supports the use of the S19 challenge strain as a safe and cost-effective method for testing Brucella vaccine candidates under BSL-2 containment conditions.
format Online
Article
Text
id pubmed-10051820
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-100518202023-03-30 Safe Subunit Green Vaccines Confer Robust Immunity and Protection against Mucosal Brucella Infection in Mice Abushahba, Mostafa F. Dadelahi, Alexis S. Lemoine, Emily L. Skyberg, Jerod A. Vyas, Swati Dhoble, Sagar Ghodake, Vinod Patravale, Vandana B. Adamovicz, Jeffrey J. Vaccines (Basel) Article Brucellosis is a zoonotic disease that causes significant negative impacts on the animal industry and affects over half a million people worldwide every year. The limited safety and efficacy of current animal brucellosis vaccines, combined with the lack of a licensed human brucellosis vaccine, have led researchers to search for new vaccine strategies to combat the disease. To this end, the present research aimed to evaluate the safety and efficacy of a green vaccine candidate that combines Brucella abortus S19 smooth lipopolysaccharide (sLPS) with Quillaja saponin (QS) or QS-Xyloglucan mix (QS-X) against mucosal brucellosis in BALB/C mice. The results of the study indicate that administering two doses of either sLPS-QS or sLPS-QS-X was safe for the animals, triggered a robust immune response, and enhanced protection following intranasal challenge with S19. Specifically, the vaccine combinations led to the secretion of IgA and IgG1 in the BALF of the immunized mice. We also found a mixed IgG1/IgG2a systemic response indicating evidence of both Th1 and Th2 activation, with a predominance of the IgG1 over the IgG2a. These candidates resulted in significant reductions in the bioburden of lung, liver, and spleen tissue compared to the PBS control group. The sLPS-QS vaccination had conferred the greatest protection, with a 130-fold reduction in Brucella burdens in lung and a 55.74-fold reduction in the spleen compared to PBS controls. Vaccination with sLPS-QS-X resulted in the highest reduction in splenic Brucella loads, with a 364.6-fold decrease in bacterial titer compared to non-vaccinated animals. The study suggests that the tested vaccine candidates are safe and effective in increasing the animals’ ability to respond to brucellosis via mucosal challenge. It also supports the use of the S19 challenge strain as a safe and cost-effective method for testing Brucella vaccine candidates under BSL-2 containment conditions. MDPI 2023-02-25 /pmc/articles/PMC10051820/ /pubmed/36992130 http://dx.doi.org/10.3390/vaccines11030546 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Abushahba, Mostafa F.
Dadelahi, Alexis S.
Lemoine, Emily L.
Skyberg, Jerod A.
Vyas, Swati
Dhoble, Sagar
Ghodake, Vinod
Patravale, Vandana B.
Adamovicz, Jeffrey J.
Safe Subunit Green Vaccines Confer Robust Immunity and Protection against Mucosal Brucella Infection in Mice
title Safe Subunit Green Vaccines Confer Robust Immunity and Protection against Mucosal Brucella Infection in Mice
title_full Safe Subunit Green Vaccines Confer Robust Immunity and Protection against Mucosal Brucella Infection in Mice
title_fullStr Safe Subunit Green Vaccines Confer Robust Immunity and Protection against Mucosal Brucella Infection in Mice
title_full_unstemmed Safe Subunit Green Vaccines Confer Robust Immunity and Protection against Mucosal Brucella Infection in Mice
title_short Safe Subunit Green Vaccines Confer Robust Immunity and Protection against Mucosal Brucella Infection in Mice
title_sort safe subunit green vaccines confer robust immunity and protection against mucosal brucella infection in mice
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051820/
https://www.ncbi.nlm.nih.gov/pubmed/36992130
http://dx.doi.org/10.3390/vaccines11030546
work_keys_str_mv AT abushahbamostafaf safesubunitgreenvaccinesconferrobustimmunityandprotectionagainstmucosalbrucellainfectioninmice
AT dadelahialexiss safesubunitgreenvaccinesconferrobustimmunityandprotectionagainstmucosalbrucellainfectioninmice
AT lemoineemilyl safesubunitgreenvaccinesconferrobustimmunityandprotectionagainstmucosalbrucellainfectioninmice
AT skybergjeroda safesubunitgreenvaccinesconferrobustimmunityandprotectionagainstmucosalbrucellainfectioninmice
AT vyasswati safesubunitgreenvaccinesconferrobustimmunityandprotectionagainstmucosalbrucellainfectioninmice
AT dhoblesagar safesubunitgreenvaccinesconferrobustimmunityandprotectionagainstmucosalbrucellainfectioninmice
AT ghodakevinod safesubunitgreenvaccinesconferrobustimmunityandprotectionagainstmucosalbrucellainfectioninmice
AT patravalevandanab safesubunitgreenvaccinesconferrobustimmunityandprotectionagainstmucosalbrucellainfectioninmice
AT adamoviczjeffreyj safesubunitgreenvaccinesconferrobustimmunityandprotectionagainstmucosalbrucellainfectioninmice